rs2075650
|
0.662 |
0.360 |
19 |
44892362 |
intron variant |
A/G
|
snv
|
0.13
|
0.13
|
Longevity
|
|
0.800 |
1.000 |
2 |
2011 |
2012 |
rs2075650
|
0.662 |
0.360 |
19 |
44892362 |
intron variant |
A/G
|
snv
|
0.13
|
0.13
|
Alzheimer Disease, Late Onset
|
Nervous System Diseases; Mental Disorders
|
0.020 |
1.000 |
2 |
2013 |
2017 |
rs2075650
|
0.662 |
0.360 |
19 |
44892362 |
intron variant |
A/G
|
snv
|
0.13
|
0.13
|
Triglycerides measurement
|
|
0.700 |
1.000 |
2 |
2012 |
2013 |
rs760136
|
1.000 |
0.080 |
19 |
44900601 |
intron variant |
A/G
|
snv
|
|
0.52
|
Alzheimer's Disease
|
Nervous System Diseases; Mental Disorders
|
0.800 |
1.000 |
2 |
2013 |
2018 |
rs8106922
|
1.000 |
0.080 |
19 |
44898409 |
intron variant |
A/G
|
snv
|
|
0.36
|
Serum total cholesterol measurement
|
|
0.700 |
1.000 |
2 |
2018 |
2019 |
rs10524523
|
0.807 |
0.200 |
19 |
44899792 |
intron variant |
TTTTTTTTTTTTTTTTTTTTTTT/-;T;TT;TTT;TTTT;TTTTT;TTTTTT;TTTTTTT;TTTTTTTT;TTTTTTTTT;TTTTTTTTTT;TTTTTTTTTTT;TTTTTTTTTTTT;TTTTTTTTTTTTT;TTTTTTTTTTTTTT;TTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
|
delins
|
|
|
Diabetes Mellitus, Non-Insulin-Dependent
|
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
0.010 |
1.000 |
1 |
2014 |
2014 |
rs10524523
|
0.807 |
0.200 |
19 |
44899792 |
intron variant |
TTTTTTTTTTTTTTTTTTTTTTT/-;T;TT;TTT;TTTT;TTTTT;TTTTTT;TTTTTTT;TTTTTTTT;TTTTTTTTT;TTTTTTTTTT;TTTTTTTTTTT;TTTTTTTTTTTT;TTTTTTTTTTTTT;TTTTTTTTTTTTTT;TTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
|
delins
|
|
|
Mental deterioration
|
Mental Disorders
|
0.010 |
1.000 |
1 |
2017 |
2017 |
rs10524523
|
0.807 |
0.200 |
19 |
44899792 |
intron variant |
TTTTTTTTTTTTTTTTTTTTTTT/-;T;TT;TTT;TTTT;TTTTT;TTTTTT;TTTTTTT;TTTTTTTT;TTTTTTTTT;TTTTTTTTTT;TTTTTTTTTTT;TTTTTTTTTTTT;TTTTTTTTTTTTT;TTTTTTTTTTTTTT;TTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
|
delins
|
|
|
Familial Alzheimer Disease (FAD)
|
Nervous System Diseases; Mental Disorders
|
0.010 |
1.000 |
1 |
2013 |
2013 |
rs10524523
|
0.807 |
0.200 |
19 |
44899792 |
intron variant |
TTTTTTTTTTTTTTTTTTTTTTT/-;T;TT;TTT;TTTT;TTTTT;TTTTTT;TTTTTTT;TTTTTTTT;TTTTTTTTT;TTTTTTTTTT;TTTTTTTTTTT;TTTTTTTTTTTT;TTTTTTTTTTTTT;TTTTTTTTTTTTTT;TTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
|
delins
|
|
|
Inclusion Body Myopathy, Sporadic
|
Musculoskeletal Diseases; Nervous System Diseases
|
0.010 |
1.000 |
1 |
2013 |
2013 |
rs10527454
|
1.000 |
0.080 |
19 |
44899792 |
intron variant |
TTTTTTTTTTTTTTTTTTTTTTT/-;T;TT;TTT;TTTT;TTTTT;TTTTTT;TTTTTTT;TTTTTTTT;TTTTTTTTT;TTTTTTTTTT;TTTTTTTTTTT;TTTTTTTTTTTT;TTTTTTTTTTTTT;TTTTTTTTTTTTTT;TTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT;TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
|
delins
|
|
|
Inclusion Body Myopathy, Sporadic
|
Musculoskeletal Diseases; Nervous System Diseases
|
0.010 |
1.000 |
1 |
2015 |
2015 |
rs115881343
|
1.000 |
0.040 |
19 |
44899959 |
intron variant |
C/G;T
|
snv
|
|
2.9E-02
|
Impaired cognition
|
Mental Disorders
|
0.010 |
1.000 |
1 |
2014 |
2014 |
rs115881343
|
1.000 |
0.040 |
19 |
44899959 |
intron variant |
C/G;T
|
snv
|
|
2.9E-02
|
Mental deterioration
|
Mental Disorders
|
0.710 |
1.000 |
1 |
2014 |
2014 |
rs1160984
|
1.000 |
0.080 |
19 |
44900667 |
intron variant |
C/T
|
snv
|
|
3.9E-02
|
Alzheimer's Disease
|
Nervous System Diseases; Mental Disorders
|
0.700 |
1.000 |
1 |
2019 |
2019 |
rs1160985
|
1.000 |
0.080 |
19 |
44900155 |
intron variant |
C/T
|
snv
|
|
0.52
|
Serum LDL cholesterol measurement
|
|
0.700 |
1.000 |
1 |
2013 |
2013 |
rs1160985
|
1.000 |
0.080 |
19 |
44900155 |
intron variant |
C/T
|
snv
|
|
0.52
|
Lipids measurement
|
|
0.700 |
1.000 |
1 |
2013 |
2013 |
rs11668327
|
1.000 |
0.080 |
19 |
44895376 |
intron variant |
G/C
|
snv
|
|
0.12
|
Alzheimer's Disease
|
Nervous System Diseases; Mental Disorders
|
0.700 |
1.000 |
1 |
2018 |
2018 |
rs11668327
|
1.000 |
0.080 |
19 |
44895376 |
intron variant |
G/C
|
snv
|
|
0.12
|
Serum albumin measurement
|
|
0.700 |
1.000 |
1 |
2012 |
2012 |
rs117310449
|
1.000 |
0.080 |
19 |
44890259 |
intron variant |
C/T
|
snv
|
|
7.3E-03
|
Alzheimer's Disease
|
Nervous System Diseases; Mental Disorders
|
0.700 |
1.000 |
1 |
2018 |
2018 |
rs157580
|
0.882 |
0.160 |
19 |
44892009 |
intron variant |
G/A
|
snv
|
|
0.69
|
Coronary heart disease
|
Cardiovascular Diseases
|
0.700 |
1.000 |
1 |
2011 |
2011 |
rs157580
|
0.882 |
0.160 |
19 |
44892009 |
intron variant |
G/A
|
snv
|
|
0.69
|
Serum total cholesterol measurement
|
|
0.700 |
1.000 |
1 |
2012 |
2012 |
rs157580
|
0.882 |
0.160 |
19 |
44892009 |
intron variant |
G/A
|
snv
|
|
0.69
|
Chronic Kidney Diseases
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
0.010 |
1.000 |
1 |
2014 |
2014 |
rs157580
|
0.882 |
0.160 |
19 |
44892009 |
intron variant |
G/A
|
snv
|
|
0.69
|
Sleep Apnea, Obstructive
|
Respiratory Tract Diseases; Nervous System Diseases
|
0.010 |
1.000 |
1 |
2008 |
2008 |
rs157580
|
0.882 |
0.160 |
19 |
44892009 |
intron variant |
G/A
|
snv
|
|
0.69
|
C-reactive protein measurement
|
|
0.700 |
1.000 |
1 |
2013 |
2013 |
rs157580
|
0.882 |
0.160 |
19 |
44892009 |
intron variant |
G/A
|
snv
|
|
0.69
|
Herpes Simplex Infections
|
Infections; Skin and Connective Tissue Diseases
|
0.010 |
1.000 |
1 |
2018 |
2018 |
rs157580
|
0.882 |
0.160 |
19 |
44892009 |
intron variant |
G/A
|
snv
|
|
0.69
|
Autoantibody measurement
|
|
0.700 |
1.000 |
1 |
2009 |
2009 |